熱點掃描 | 港股多數板塊下行，恆科大跌2.8%
uSMART盈立智投7月2日消息，港股三大指數下挫，截止發稿，恆指跌1.52%，報28390.01，成交額628.54億，國企指數跌1.92%，恆生科技指數大跌2.83%，港股通淨流出15.73億。
紙業股逆勢大漲，截止10:30，理文造紙、玖龍紙業均大漲超9%，晨鳴紙業漲超3%。
石油股走高，截止10:30，但漲幅縮窄，中石油漲超3%，集團預計上半年淨利將增加750億元-900億元，同比扭虧爲盈；中海油漲超1%，中石化漲幅不足1%。消息面上，OPEC+代表表示，沙特和俄羅斯就提高石油產量達成初步協議，2021年12月前平均每月增產40萬桶/日，8-12月累計增產200萬桶/日，增產數值低於此前市場預期。
中醫藥板塊造好，截止10:30，現代中藥集團漲超6%，白雲山漲超2%，同仁堂國藥、中國中藥漲超1%。此前，四部委表示，更好發揮中醫藥特色和比較優勢，建設30個左右國家中醫藥傳承創新中心。
恆生科技指數下挫，截止10:30，京東健康、舜宇、萬國數據、微盟集團、華虹半導體、比亞迪電子均跌超4%，阿裏、百度、快手、小米、美團均跌超3%，阿裏巴巴宣佈組織升級：打通高德飛豬本地生活組成生活服務板塊；中芯國際跌超2%，網易、b站、京東跌超1%，騰訊跌幅不足1%；ASM太平洋逆勢上漲超3%。
汽車股走低，截止10:30，吉利汽車、比亞迪股份跌超5%，比亞迪股價一度下跌6.5%，爲6月16日以來最大跌幅；雅迪控股跌超4%，長城汽車、恆大汽車均跌超2%，廣汽跌1%。
光伏板塊跌幅居前，截止10:30，信義光能跌超6%，福萊特玻璃跌超5%，福耀玻璃跌超4%，金風科技跌超3%，新特能源跌超2%。
個股方面，截止10:30，中升控股漲超7%，盤中漲超9%，創歷史新高，公司擬斥13億美元收購汽車經銷商仁孚中國；藥明巨諾-B再跌超8%，“奕凱達”低藥價傳聞衝擊疊加股東減持利空；綠葉製藥漲超4%，擬分拆博安生物並將其獨立上市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
